B7 costimulation and intracellular indoleamine-2,3-dioxygenase (IDO) expression in peripheral blood of healthy pregnant and non-pregnant women

Abstract

BackgroundB7 costimulatory molecules are expressed on antigen presenting cells (APCs) and are important regulators of T cell activation. We investigated the role of the B7 family of costimulatory molecules in the development of the systemic maternal immune tolerance during healthy pregnancy (HP). We also aimed to investigate the intracellular expression of indoleamine-2,3-dioxygenase (IDO) and plasma levels of tryptophane (TRP), kynurenine (KYN) and kynurenic acid (KYNA), important molecules with immunoregulatory properties, in order to describe their potential contribution to the pregnancy-specific maternal immune tolerance.MethodsWe determined the frequency of activated (CD11b+) monocytes expressing B7-1, B7-2, B7-H1, and B7-H2, and that of T cells and CD4+ T helper cells expressing CD28, CTLA-4, PD-1, and ICOS in peripheral blood samples of healthy pregnant (HP) and non-pregnant (NP) women using flow cytometry. We also examined the intracellular expression of IDO applying flow cytometry and plasma levels of TRP, KYN and KYNA using high-performance liquid chromatography.ResultsA significant increase in the prevalence of CD28+ T cells was observed in HP compared to NP women. At the same time a decrease was shown in the expression of CTLA-4 on these cells. The frequency of CD80+ monocytes was lower in HP women. The prevalence of IDO-expressing T cells and monocytes was higher in HP compared to NP women. Plasma KYN, KYNA and TRP levels were lower, while at the same time, the KYN/TRP ratio was higher in HP than in NP women.ConclusionsCostimulation via CD28 may not contribute to the immunosuppressive environment, at least in the third trimester of pregnancy. The development of the pregnancy-specific immune tolerance in the mechanism of B7 costimulation may be more related to the altered expression of B7 proteins on APCs rather than that of their receptors on T cells. The elevated intracellular IDO expression in monocytes and T cells, as well as higher plasma enzymatic IDO activity are likely to contribute to the systemic immunosuppressive environment in the third trimester characteristic for healthy gestation.Electronic supplementary materialThe online version of this article (doi:10.1186/1471-2393-14-306) contains supplementary material, which is available to authorized users.

Maternal and Fetal CD4+CD25+CD127low/- Regulatory T Cells in Pregnancies with Gestational Diabetes, Preeclampsia, and Premature Rupture of Membranes

“…Studies have shown that PD-1 + T cells seem to be increased in healthy pregnant women compared to non-pregnant women [68], while decreased PD-1 + T cells were observed in PE and GDM [69][70][71]. In our studies, we found that PD-1 + Tregs in CB, PD-1 + Tregs and GITR + Tregs in PB from PE, GDM, and PROM were lower compared to those of NP.…”

The Role of B7 Family Molecules in Maternal–Fetal Immunity

“…Macrophages in term placentas strongly express the B7-H2 protein (64). The expression of ICOS, a simulator of T-cell activation, is strongly elevated in healthy pregnant women, whereas its corresponding costimulatory molecule B7-H2 is decreased on monocytes of pregnant women compared with those of non-pregnant women (69). In an allogeneic CBA female × B6 male pregnancy model, blockade of the ICOS-B7-H2 pathway results in increased fetal absorption and a decreased fetal survival rate.…”

The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer

“…PD-L1 expression by Treg cells has been found to inhibit proliferation of CD4 + CD25 − T cells and suppress expression of the pro-inflammatory cytokines IFN-γ and TNF-α (224). PD-1 expression on T cells seem to be increased in healthy pregnancy compared to non-pregnant women (225), while reduced levels of PD-1 and PD-L1 have been suggested to promote Th17 proliferation, thus causing the Treg/Th17 imbalance observed in PE (226). Consistent with this, mice studies have shown that blocking of PD-L1 results in lower numbers of Tregs and increased Teff and Th17 populations, as well as increased fetal resorption and reduced litter size (227, 228).…”